RxDoctor Payments Data

William Rossy, MD

Orthopaedic Surgery · Princeton, NJNPI 1891012183

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Seapearl East, Inc at 26.0% of the total. Reporting peaked in 2019 at $1,139 and has fallen 83.8% since, to $185 in 2025.

$3,960in general payments, 2019–2025

Across 46 payments — averaging $86.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Seapearl East, Inc$1K
  • Medical Device Business Services, Inc.$889
  • Linvatec Corporation$539
  • Johnson & Johnson$456
  • Acera Surgical, Inc.$215
  • Encore Medical, LP$180
  • plus $652 from 13 others
$276,093in research payments, 2019–2025

Across 22 payments — averaging $12,550 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$276K

What the payments were for

  • Travel & lodging$1,21631%
  • Food & beverage$1,82046%
  • Education$92323%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,960 in reported general payments places this provider in the 55th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$341,347
Medicare patients
548
Services billed
17,672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam192$537
Celecoxib23$212
Tramadol Hcl13$151
Diazepam11$35

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Princeton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →